» Articles » PMID: 22784495

Continuous Labeling of Circulating Tumor Cells with Microbeads Using a Vortex Micromixer for Highly Selective Isolation

Overview
Date 2012 Jul 13
PMID 22784495
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Circulating tumor cells (CTCs) are identified in transit within the blood stream of cancer patients and have been proven to be a main cause of metastatic disease. Current approaches for the size-based isolation of CTCs have encountered technical challenges as some of the CTCs have a size similar to that of leukocytes and therefore CTCs are often lost in the process. Here, we propose a novel strategy where most of the CTCs are coated by a large number of microbeads to amplify their size to enable complete discrimination from leukocytes. In addition, all of the microbead labeling processes are carried out in a continuous manner to prevent any loss of CTCs during the isolation process. Thus, a microfluidic mixer was employed to facilitate the efficient and selective labeling of CTCs from peripheral blood samples. By generating secondary vortex flows called Taylor-Gortler vortices perpendicular to the main flow direction in our microfluidic device, CTCs were continuously and successfully coated with anti-epithelial cell adhesion molecule-conjugated beads. After the continuous labeling, the enlarged CTCs were perfectly trapped in a micro-filter whereas all of the leukocytes escaped.

Citing Articles

MCAM/MUC18/CD146 as a Multifaceted Warning Marker of Melanoma Progression in Liquid Biopsy.

Rapanotti M, Cugini E, Nuccetelli M, Terrinoni A, Di Raimondo C, Lombardo P Int J Mol Sci. 2021; 22(22).

PMID: 34830300 PMC: 8623757. DOI: 10.3390/ijms222212416.


Detection of circulating tumor cells: Advances and critical concerns.

Hu X, Zang X, Lv Y Oncol Lett. 2021; 21(5):422.

PMID: 33850563 PMC: 8025150. DOI: 10.3892/ol.2021.12683.


Paramagnetic Structures within a Microfluidic Channel for Enhanced Immunomagnetic Isolation and Surface Patterning of Cells.

Sun C, Hassanisaber H, Yu R, Ma S, Verbridge S, Lu C Sci Rep. 2016; 6:29407.

PMID: 27388549 PMC: 4937384. DOI: 10.1038/srep29407.


Emerging platforms using liquid biopsy to detect EGFR mutations in lung cancer.

Lin C, Huang W, Wei F, Su W, Wong D Expert Rev Mol Diagn. 2015; 15(11):1427-40.

PMID: 26420338 PMC: 4889428. DOI: 10.1586/14737159.2015.1094379.


Effective capture of circulating tumor cells from a transgenic mouse lung cancer model using dendrimer surfaces immobilized with anti-EGFR.

Myung J, Roengvoraphoj M, Tam K, Ma T, Memoli V, Dmitrovsky E Anal Chem. 2015; 87(19):10096-102.

PMID: 26312815 PMC: 4734638. DOI: 10.1021/acs.analchem.5b02766.